Legal Representation
Attorney
Karima Gulick
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 5, 2022 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Apr 5, 2022 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 22, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 22, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 22, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jul 30, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 29, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 29, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 29, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 29, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 29, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 23, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 23, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 23, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 22, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 22, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 22, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 13, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 16, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 13, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 3, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 27, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Plant extracts for medical, veterinary and pharmaceutical purposes; Medicinal herbs in dried or preserved form; Liquid herbal supplements; Medicinal oils; Dietary and nutritional supplements containing ingredients derived from hemp for medicinal use; Nutritional supplements for treating anxiety and depression, relieving chronic pain, improving sleep quality, increasing energy and endurance, promoting healthy skin; Transdermal patches featuring ingredients derived from hemp for medicinal use of reducing anxiety and depression, relieving chronic pain, improving sleep quality, increasing energy and endurance, promoting healthy skin; Medicinal drinks; Dietary beverage supplements for human consumption in liquid, dry mix, and tablet form for therapeutic purposes containing ingredients derived from hemp; Medicinal preparations for the mouth and as sprays; Medicinal tea; Herbal teas for medicinal purposes; Antioxidant enriched coffee for medical purposes; Medicated candies; Medicated confectionery; Sweets for medicinal purposes; Medicated chewing gum; Vitamin and mineral formed and packaged as bars; Food supplements; Vitamins and dietary food supplements for animals; Pharmaceutical preparations for animal skincare; Medicated dermatological preparations and substances; Medicated massage oils; Anti-inflammatory ointments; Preparation for the relief of pain; Headache treatment preparations; Therapeutic spray to soothe and relax the muscles; Medicated lip balm; Balms for pharmaceutical purposes; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners, peels, moisturizers, clays, masks; Medicated cosmetics; Therapeutic medicated bath preparations; Bath salts and bath preparations for medical purposes; all of the foregoing containing ingredients solely derived from hemp with a delta-9 tetrahyrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Classification
International Classes
005